Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Infertility: HELP
Ann H. Partridge
Based on 14 articles published since 2007
||||
Expertise Level
The expertise of Ann H. Partridge ranks in the
  • Top 0.014%
  • ... of 51,294 published authors worldwide on Infertility
  • ... from 2007 through 2018
  • ... based on contributions to 14 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Partridge, A   ·   Partridge, Ann   ·   Partridge, Ann H
Work Locations
Details
Most likely:    Harvard University   Contact    
2017
  • Departamento de Investigacion y de Tumores Mamarios, Instituto Nacional de Cancerologia, Mexico City, Mexico; Centro de Cancer de Mama, Tecnologico de Monterrey, Monterrey, N.L., Mexico; Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico. · Centro de Cancer de Mama, Tecnologico de Monterrey, Monterrey, N.L., Mexico; Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico. · Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico. · Departamento de Investigacion y de Tumores Mamarios, Instituto Nacional de Cancerologia, Mexico City, Mexico; Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Centro de Cancer de Mama, Tecnologico de Monterrey, Monterrey, N.L., Mexico. · Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico; Catedras CONACYT, Instituto Nacional de Cancerologia, Mexico. Electronic address: · Pubmed 28284061
2016
  • From the Department of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts. From the Department of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts. · Pubmed 26957619
  • Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino - IST, Genoa, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino - IST, Genoa, Italy. · Physiopathology of Human Reproduction, IRCCS AOU San Martino - IST, Genoa, Italy. · Laboratory of Reproductive Biology, Section 5712, Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Universit√© Libre de Bruxelles, Brussels, Belgium. · Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy. · Reproductive Medicine Department, International Evangelic Hospital, Genoa, Italy. · Physiopathology of Reproduction and In Vitro Fertilization Unit, S. Anna Hospital, University of Turin, Turin, Italy. · Department of Medical Oncology, E.O. Galliera, Genoa, Italy. · GENERA Centre for Reproductive Medicine, Clinica Valle Giulia, Rome, Italy. · Obstetric and Gynecology Department, Azienda Ospedaliera Arcispedale S. Maria Nuova-IRCCS, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · Children and Women Health Department, Physiopathology of Human Reproduction Unit, "San Giuseppe Moscati" Hospital, Avellino, Italy. · Department of Haematology/Oncology, Royal Hospital for Sick Children, and Department of Child Life and Health, University of Edinburgh, Edinburgh, UK. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 26728489
2015
  • Dana-Farber Cancer Institute, Boston, MA (SMR, AHP). · Dana-Farber Cancer Institute, Boston, MA (SMR, AHP). · Pubmed 26307642
2014
  • Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA · Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA. · Pubmed 24951610
2010
  • Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 19409543
2007
  • Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 44 Binney Street, D1210 Boston, MA 02115, USA. · Pubmed 17804236
2014
  • Kathryn J. Ruddy, Shari I. Gelber, Meghan E. Meyer, and Ann H. Partridge, Dana-Farber Cancer Institute; Rulla M. Tamimi and Elizabeth S. Ginsburg, Brigham and Women's Hospital; Lidia Schapira, Massachusetts General Hospital; Steven E. Come, Beth Israel Deaconess Medical Center, Boston, MA; and Virginia F. Borges, University of Colorado Denver, Aurora, CO. · Pubmed 24567428
2012
Probable:    New York Medical College   Contact    
2014
  • Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA · Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA. · Pubmed 24951610
2013
  • Institute for Fertility Preservation, New York Medical College, Rye, NY, USA. · Pubmed 23715580
Probable:    Centers for Disease Control      
2014
  • Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA · Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA. · Pubmed 24951610
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 14 total) written by Ann H. Partridge about Infertility:

  • Fertility concerns among breast cancer patients in Mexico. 2017
  • Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and Safety. 2016
  • Cancer and fertility preservation: international recommendations from an expert meeting. 2016
  • New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer. 2015
  • Estimates of young breast cancer survivors at risk for infertility in the U.S. 2014
  • Prospective study of fertility concerns and preservation strategies in young women with breast cancer. 2014
  • Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. 2013
  • Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain. 2013
  • Fertility (male and female) and menopause. 2012
  • The unique reproductive concerns of young women with breast cancer. 2012
Show List of Full Article Records
Google Searches

Learn more about Ann H. Partridge using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
New York Medical College
Centers for Disease Control
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University
2017
  • Departamento de Investigacion y de Tumores Mamarios, Instituto Nacional de Cancerologia, Mexico City, Mexico; Centro de Cancer de Mama, Tecnologico de Monterrey, Monterrey, N.L., Mexico; Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico. · Centro de Cancer de Mama, Tecnologico de Monterrey, Monterrey, N.L., Mexico; Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico. · Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico. · Departamento de Investigacion y de Tumores Mamarios, Instituto Nacional de Cancerologia, Mexico City, Mexico; Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Centro de Cancer de Mama, Tecnologico de Monterrey, Monterrey, N.L., Mexico. · Joven y Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico; Catedras CONACYT, Instituto Nacional de Cancerologia, Mexico. Electronic address: · Pubmed 28284061
2016
  • From the Department of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts. From the Department of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts. · Pubmed 26957619
  • Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino - IST, Genoa, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino - IST, Genoa, Italy. · Physiopathology of Human Reproduction, IRCCS AOU San Martino - IST, Genoa, Italy. · Laboratory of Reproductive Biology, Section 5712, Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Universit√© Libre de Bruxelles, Brussels, Belgium. · Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy. · Reproductive Medicine Department, International Evangelic Hospital, Genoa, Italy. · Physiopathology of Reproduction and In Vitro Fertilization Unit, S. Anna Hospital, University of Turin, Turin, Italy. · Department of Medical Oncology, E.O. Galliera, Genoa, Italy. · GENERA Centre for Reproductive Medicine, Clinica Valle Giulia, Rome, Italy. · Obstetric and Gynecology Department, Azienda Ospedaliera Arcispedale S. Maria Nuova-IRCCS, University of Modena and Reggio Emilia, Reggio Emilia, Italy. · Children and Women Health Department, Physiopathology of Human Reproduction Unit, "San Giuseppe Moscati" Hospital, Avellino, Italy. · Department of Haematology/Oncology, Royal Hospital for Sick Children, and Department of Child Life and Health, University of Edinburgh, Edinburgh, UK. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 26728489
2015
  • Dana-Farber Cancer Institute, Boston, MA (SMR, AHP). · Dana-Farber Cancer Institute, Boston, MA (SMR, AHP). · Pubmed 26307642
2014
  • Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA · Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA. · Pubmed 24951610
2010
  • Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 19409543
2007
  • Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 44 Binney Street, D1210 Boston, MA 02115, USA. · Pubmed 17804236
2014
  • Kathryn J. Ruddy, Shari I. Gelber, Meghan E. Meyer, and Ann H. Partridge, Dana-Farber Cancer Institute; Rulla M. Tamimi and Elizabeth S. Ginsburg, Brigham and Women's Hospital; Lidia Schapira, Massachusetts General Hospital; Steven E. Come, Beth Israel Deaconess Medical Center, Boston, MA; and Virginia F. Borges, University of Colorado Denver, Aurora, CO. · Pubmed 24567428
2012
New York Medical College
2014
  • Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA · Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA. · Pubmed 24951610
2013
  • Institute for Fertility Preservation, New York Medical College, Rye, NY, USA. · Pubmed 23715580
Centers for Disease Control
2014
  • Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA · Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ICF International, Rockville, Maryland, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Reproductive Medicine and Laboratory of Fertility Preservation and Molecular Reproduction, New York Medical College, Valhalla, New York, USA; Innovation Institute for Fertility Preservation, New York, New York, USA. · Pubmed 24951610
3 Other Locations Show
Yearly article counts 012122211011
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.